Nuvalent (NUVL) officer Benjamin Lane details stock, options and RSUs in Form 3

Rhea-AI Filing Summary

Nuvalent, Inc. officer Benjamin Lane filed an initial ownership report, listing his equity stake in the company. He directly holds 40,868 shares of Class A Common Stock, along with multiple stock options and restricted stock units that may convert into additional shares over time.

The filing shows stock options over 731, 8,333, 17,848, 15,052, 12,025 and 8,000 shares of Class A Common Stock, with exercise prices from $14.40 to $106.82 and expirations between 2032 and 2036. Footnotes also describe RSUs covering 6,733, 5,200 and 8,000 shares that vest in installments, subject to continued service. The Form 3 reflects holdings rather than new buy or sell transactions.

Insights

Equity compensation analyst

Form 3 shows Lane’s existing Nuvalent equity, no new trades.

The filing details Benjamin Lane’s baseline ownership in Nuvalent, Inc., combining common shares, stock options and RSUs. This is an initial beneficial-ownership snapshot, not a record of fresh market purchases or sales.

Lane holds 40,868 shares of Class A Common Stock plus several option grants with exercise prices from $14.40 to $106.82 and expirations through 2036. Footnotes describe RSUs granted in 2024, 2025 and 2026 that vest over time if service continues.

Because no open-market buy or sell codes appear and transaction counts for purchases and sales are zero, this information is administratively important but not thesis-changing. Future company filings may update these holdings as options vest, RSUs settle, or any actual trades occur.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lane Benjamin

(Last) (First) (Middle)

C/O NUVALENT, INC.

ONE BROADWAY, 14TH FLOOR

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2026

3. Issuer Name and Ticker or Trading Symbol
Nuvalent, Inc. [ NUVL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock	40,868(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(2)	01/04/2032	Class A Common Stock	731	$18.93	D
Stock Option (Right to Buy)	(3)	08/01/2032	Class A Common Stock	8,333	$14.4	D
Stock Option (Right to Buy)	(4)	01/06/2033	Class A Common Stock	17,848	$27.85	D
Stock Option (Right to Buy)	(5)	01/05/2034	Class A Common Stock	15,052	$72.35	D
Stock Option (Right to Buy)	(6)	01/06/2035	Class A Common Stock	12,025	$78.09	D
Stock Option (Right to Buy)	(7)	01/07/2036	Class A Common Stock	8,000	$106.82	D

Explanation of Responses:

1. Includes (i) 6,733 shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs") granted on January 5, 2024, (ii) 5,200 shares of Nuvalent, Inc. Class A Common Stock issuable under RSUs granted on January 6, 2025, and (iii) 8,000 shares of Nuvalent, Inc. Class A Common Stock issuable under RSUs granted on January 7, 2026. Each RSU represents the right to receive one share of Nuvalent, Inc. Class A Common Stock. The RSUs vest in three equal annual installments following the applicable grant date, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

2. The shares underlying this option are fully vested.

3. The shares underlying this option vest as follows: 25% of the 50,000 shares originally underlying the option vested on August 1, 2023 and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

4. The 65,900 shares originally underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

5. The 28,900 shares originally underlying this option have vested or shall vest over the four years following January 5, 2024 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

6. The 15,600 shares originally underlying this option have vested or shall vest over the four years following January 6, 2025 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

7. The shares underlying this option have vested or shall vest over the four years following January 7, 2026 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

Remarks:

Chief Technical Operations Officer Exhibit 24: Power of Attorney

	/s/ Nathan N. McConarty, attorney-in-fact	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Benjamin Lane’s Form 3 for Nuvalent (NUVL) report?

The Form 3 reports Benjamin Lane’s initial ownership in Nuvalent, Inc., including 40,868 Class A Common shares, multiple stock option grants, and several time-vesting RSU awards. It establishes his baseline equity position as a company officer, without recording new market trades.

How many Nuvalent (NUVL) common shares does Benjamin Lane directly hold?

Benjamin Lane directly holds 40,868 shares of Nuvalent Class A Common Stock. This figure reflects his current direct share ownership as reported, separate from additional shares that could be acquired later through vested stock options or restricted stock unit settlements described in the filing.

What stock options are listed for Benjamin Lane in the Nuvalent (NUVL) Form 3?

The Form 3 lists several stock options over 731, 8,333, 17,848, 15,052, 12,025 and 8,000 Nuvalent Class A shares, with exercise prices from $14.40 to $106.82. These options expire between 2032 and 2036, and some are already fully vested according to the footnotes.

What RSU awards does Benjamin Lane hold at Nuvalent (NUVL)?

Footnotes describe RSUs for 6,733, 5,200 and 8,000 shares of Nuvalent Class A Common Stock, granted in 2024, 2025 and 2026. Each RSU converts into one share, vesting in three equal annual installments, conditioned on Lane’s continued service with the company.

Does Benjamin Lane’s Nuvalent (NUVL) Form 3 show any stock purchases or sales?

The Form 3 does not show any stock purchases or sales. All entries are classified as holdings, with zero buy and sell transactions in the transaction summary. It primarily catalogs Lane’s existing shares, stock options and RSUs rather than recording new trading activity.

What is the significance of the vesting schedules in Benjamin Lane’s Nuvalent (NUVL) equity awards?

The vesting schedules determine when Lane actually earns shares from RSUs and options. Footnotes state that RSUs and options vest in monthly or annual installments over several years, subject to continued service. This ties a portion of his compensation to long-term employment at Nuvalent.